Reliability evaluation of nonlinear design space in pharmaceutical product development

被引:13
|
作者
Hayashi, Yoshihiro [1 ]
Kikuchi, Shingo [1 ]
Onuki, Yoshinori [1 ]
Takayama, Kozo [1 ]
机构
[1] Hoshi Univ, Dept Pharmaceut, Shinagawa Ku, Tokyo 1428501, Japan
关键词
multivariate analysis; simulations; formulation; solid dosage form; nonlinear regression; excipients; stability; dissolution rate; RESPONSE-SURFACE METHOD; BOOTSTRAP RESAMPLING TECHNIQUE; ARTIFICIAL NEURAL-NETWORKS; FORMULATION OPTIMIZATION; PERCUTANEOUS-ABSORPTION; SPLINE INTERPOLATION; RELEASE TABLET; HYDROGEL; DELIVERY; PATCH;
D O I
10.1002/jps.22734
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Formulation design space of indomethacin tablets was investigated using a nonlinear response surface method incorporating multivariate spline interpolation (RSM-S). In this study, a resampling method with replacement was applied to evaluate the reliability of border on the design space estimated by RSM-S. The quantities of lactose, cornstarch, and microcrystalline cellulose were chosen as the formulation factors. Response surfaces were estimated using RSM-S, and the nonlinear design space was defined under the restriction of more than 3 kgf hardness and more than 70% dissolution 30 min before and after an accelerated test. The accuracy of the resampling method was elucidated and high correlation coefficients were produced. However, the distribution of the border on the design space generated by the resampling method was far from normal, and the confidence interval of the border was estimated using a nonparametric percentile technique. Consequently, the reliability of the design space was decreased by approaching the edge of the experimental design. RSM-S and this resampling method might be useful for estimating the reliability of nonlinear design space. (c) 2011 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101:333-341, 2012
引用
收藏
页码:333 / 341
页数:9
相关论文
共 50 条
  • [31] Conceptual Model and Evaluation of Design Characteristics in Product Development
    Ivandic, Zeljko
    Ergic, Todor
    Kokanovic, Mato
    STROJARSTVO, 2009, 51 (04): : 281 - 291
  • [32] Pharmaceutical challenges in veterinary product development
    Ahmed, M
    Kasraian, K
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (06) : 871 - 882
  • [33] Benchmarking biotech and pharmaceutical product development
    Donald L Drakeman
    Nature Biotechnology, 2014, 32 : 621 - 625
  • [34] Benchmarking biotech and pharmaceutical product development
    Drakeman, Donald L.
    NATURE BIOTECHNOLOGY, 2014, 32 (07) : 621 - 625
  • [35] Information Modeling for Pharmaceutical Product Development
    Zhao, Chunhua
    Hailemariam, Leaelaf
    Jain, Ankur
    Joglekar, Girish
    Venkatasubramanian, Venkat
    Morris, Kenneth
    Reklaitis, Gintaras
    16TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING AND 9TH INTERNATIONAL SYMPOSIUM ON PROCESS SYSTEMS ENGINEERING, 2006, 21 : 2147 - 2152
  • [36] Role of nanotechnology in pharmaceutical product development
    Devalapally, Harikrishna
    Chakilam, Ananthsrinivas
    Amiji, Mansoor M.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (10) : 2547 - 2565
  • [37] Reliability analysis in product development
    Galetto, F
    AMST '05: ADVANCED MANUFACTURING SYSTEMS AND TECHNOLOGY, PROCEEDINGS, 2005, (486): : 713 - 724
  • [38] Pharmaceutical informatics: A novel paradigm for pharmaceutical product development and manufacture
    Zhao, CH
    Joglekar, G
    Jain, A
    Venkatasubramanian, V
    Reklaitis, GV
    European Symposium on Computer-Aided Process Engineering-15, 20A and 20B, 2005, 20a-20b : 1561 - 1566
  • [39] Design Space Investigation for Development of Continuous Flow Syntheses of Active Pharmaceutical Ingredients
    Diab, Samir
    Gerogiorgis, Dimitrios, I
    30TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, PTS A-C, 2020, 48 : 961 - 966
  • [40] APPLICATION OF NEURAL COMPUTING IN PHARMACEUTICAL PRODUCT DEVELOPMENT - COMPUTER-AIDED FORMULATION DESIGN
    HUSSAIN, AS
    SHIVANAND, P
    JOHNSON, RD
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (10) : 1739 - 1752